Article
E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society - 1 Nov 2020
Bruijstens Arlette L, Lechner Christian, Flet-Berliac Lorraine, Deiva Kumaran, Neuteboom Rinze F, Hemingway Cheryl, Wassmer Evangeline, Baumann M, Bartels F, Finke C, Adamsbaum C, Hacohen Y, Rostasy K
Abstract excerpt
Over the past few years, increasing interest in the role of autoantibodies against myelin oligodendrocyte glycoprotein (MOG-abs) as a new candidate biomarker in demyelinating central nervous system diseases has arisen. MOG-abs have now consistently been identified in a variety of demyelinating syndromes, with a predominance in paediatric patients. The clinical spectrum of these MOG-ab-associated disorders (MOGAD)...
Topics
- Adolescent
- Autoantibodies
- Autoantigens
- Child
- Demyelinating Autoimmune Diseases, CNS
- Female
- Humans
- Male
- Myelin-Oligodendrocyte Glycoprotein